Alignment Healthcare, Inc.
General ticker "ALHC" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $2.9B (TTM average)
Alignment Healthcare, Inc. follows the US Stock Market performance with the rate: 6.7%.
Estimated limits based on current volatility of 2.3%: low 19.10$, high 19.99$
Factors to consider:
- Total employees count: 1679 (+9.3%) as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: History of net losses and potential unprofitability, Limited operating history, Strategic risks and growth management, Senior management dependency, Regulatory and compliance
- Current price 10.4% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [9.90$, 17.57$]
- 2025-12-31 to 2026-12-31 estimated range: [10.23$, 18.07$]
Financial Metrics affecting the ALHC estimates:
- Negative: with PPE of -15.9 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Interest expense per share per price, % of 1.14 <= 3.41
- Positive: Investing cash flow per share per price, % of 1.90 > -0.66
- Positive: -8.75 < Industry operating profit margin (median), % of 1.70
- Positive: Industry earnings per price (median), % of 5.51 > 4.43
Short-term ALHC quotes
Long-term ALHC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,434.16MM | $1,823.63MM | $2,703.56MM |
| Operating Expenses | $1,562.80MM | $1,951.45MM | $2,805.12MM |
| Operating Income | $-128.64MM | $-127.82MM | $-101.56MM |
| Non-Operating Income | $-20.66MM | $-20.38MM | $-26.50MM |
| Interest Expense | $18.29MM | $21.23MM | $23.55MM |
| Income(Loss) | $-149.30MM | $-148.19MM | $-128.05MM |
| Taxes | $0.34MM | $-0.02MM | $0.02MM |
| Profit(Loss)* | $-149.55MM | $-148.02MM | $-128.03MM |
| Stockholders Equity | $238.13MM | $156.95MM | $99.85MM |
| Assets | $633.86MM | $591.88MM | $782.06MM |
| Operating Cash Flow | $-45.43MM | $-59.19MM | $34.77MM |
| Capital expenditure | $23.77MM | $35.99MM | $41.42MM |
| Investing Cash Flow | $-28.22MM | $-147.26MM | $39.19MM |
| Financing Cash Flow | $16.59MM | $0.10MM | $156.03MM |
| Earnings Per Share** | $-0.83 | $-0.79 | $-0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.